<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(4)</volume><submitter>Al Hadidi S</submitter><funding>NCI NIH HHS</funding><journal>Blood advances</journal><pagination>950-953</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11934280</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.</pubmed_title><pmcid>PMC11934280</pmcid><funding_grant_id>P01 CA055819</funding_grant_id><pubmed_authors>Sawyer J</pubmed_authors><pubmed_authors>Bailey C</pubmed_authors><pubmed_authors>Schinke C</pubmed_authors><pubmed_authors>Barlogie B</pubmed_authors><pubmed_authors>Siegel ER</pubmed_authors><pubmed_authors>Al Hadidi S</pubmed_authors><pubmed_authors>Panozzo S</pubmed_authors><pubmed_authors>Thanendrarajan S</pubmed_authors><pubmed_authors>Shaughnessy J</pubmed_authors><pubmed_authors>Ababneh O</pubmed_authors><pubmed_authors>Smith R</pubmed_authors><pubmed_authors>Zangari M</pubmed_authors><pubmed_authors>Tricot G</pubmed_authors><pubmed_authors>Alapat D</pubmed_authors><pubmed_authors>Zhan F</pubmed_authors><pubmed_authors>van Rhee F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-02T06:35:31.622Z</modification><creation>2026-04-15T03:15:35.64Z</creation></dates><accession>S-EPMC11934280</accession><cross_references><pubmed>39786380</pubmed><doi>10.1182/bloodadvances.2024014889</doi></cross_references></HashMap>